Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%
- 10 August 1999
- journal article
- clinical trial
- Published by Elsevier in Antiviral Research
- Vol. 43 (1) , 55-63
- https://doi.org/10.1016/s0166-3542(99)00033-9
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Modulation of TH1 and TH2 Cytokine Production with the Immune Response Modifiers, R-848 and ImiquimodCellular Immunology, 1999
- Imiquimod 5% cream (Aldara™)Expert Opinion on Investigational Drugs, 1998
- Status of Local Cellular Immunity in Interferon-Responsive and -Nonresponsive Human Papillomavirus-Associated LesionsSexually Transmitted Diseases, 1996
- Activation of Local Cell-Mediated Immunity in Interferon-Responsive Patients with Human Papillomavirus-Associated LesionsJournal of Interferon & Cytokine Research, 1996
- Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells.Journal of Clinical Investigation, 1996
- Effect of Interferon Therapy on Human Papillomavirus Copy Number in Patients With Condyloma AcuminatumThe Lancet Healthy Longevity, 1995
- Human Papillomavirus Infection and Genital Warts: Update on Epidemiology and TreatmentClinical Infectious Diseases, 1995
- Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGFβ1/IFNβ cytokine pathwayAntiviral Research, 1994
- Direct sequencing of consensus primer generated PCR fragments of human papillomavirusesJournal of Virological Methods, 1993
- Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infectionAntiviral Research, 1988